Články se zplnomocněním k veřejnému přístupu - Martin GengenbacherDalší informace
Dostupné někde: 54
Mycobacterium tuberculosis: success through dormancy
M Gengenbacher, SHE Kaufmann
FEMS microbiology reviews 36 (3), 514-532, 2012
Zplnomocnění: US National Institutes of Health
Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis
OT Schubert, C Ludwig, M Kogadeeva, M Zimmermann, G Rosenberger, ...
Cell Host & Microbe, 2015
Zplnomocnění: European Commission
The Mtb Proteome Library: A Resource of Assays to Quantify the Complete Proteome of Mycobacterium tuberculosis
OT Schubert, J Mouritsen, C Ludwig, HL Röst, G Rosenberger, PK Arthur, ...
Cell host & microbe 13 (5), 602-612, 2013
Zplnomocnění: Swiss National Science Foundation, US National Institutes of Health
Rifabutin is active against Mycobacterium abscessus complex
DB Aziz, JL Low, ML Wu, M Gengenbacher, JWP Teo, V Dartois, T Dick
Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00155-17, 2017
Zplnomocnění: National Medical Research Council, Singapore
Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
A Vogelzang, C Perdomo, U Zedler, S Kuhlmann, R Hurwitz, ...
The Journal of infectious diseases 210 (12), 1928-1937, 2014
Zplnomocnění: US National Institutes of Health
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis
S Li, NC Poulton, JS Chang, ZA Azadian, MA DeJesus, N Ruecker, ...
Nature Microbiology 7 (6), 766-779, 2022
Zplnomocnění: Bill & Melinda Gates Foundation, US Department of Defense, US National …
Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing
RA Rienksma, M Suarez-Diez, HJ Mollenkopf, GM Dolganov, A Dorhoi, ...
BMC genomics 16, 1-15, 2015
Zplnomocnění: US National Institutes of Health, Netherlands Organisation for Scientific …
Pyrazinamide triggers degradation of its target aspartate decarboxylase
P Gopal, JP Sarathy, M Yee, P Ragunathan, J Shin, S Bhushan, J Zhu, ...
Nature communications 11 (1), 1661, 2020
Zplnomocnění: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Pyrazinamide resistance is caused by two distinct mechanisms: prevention of Coenzyme A depletion and loss of virulence factor synthesis
P Gopal, M Yee, J Sarathy, JL Low, JP Sarathy, F Kaya, V Dartois, ...
ACS Infectious Diseases 2 (9), 616-626, 2016
Zplnomocnění: US National Institutes of Health, National Medical Research Council, Singapore
Integration of metabolomics and transcriptomics reveals a complex diet of Mycobacterium tuberculosis during early macrophage infection
M Zimmermann, M Kogadeeva, M Gengenbacher, G McEwen, ...
MSystems 2 (4), 10.1128/msystems. 00057-17, 2017
Zplnomocnění: European Commission
The BCG replacement vaccine VPM1002: from drawing board to clinical trial
SHE Kaufmann, MF Cotton, B Eisele, M Gengenbacher, L Grode, ...
Expert review of vaccines 13 (5), 619-630, 2014
Zplnomocnění: Wellcome Trust
Indole propionic acid, an unusual antibiotic produced by the gut microbiota, with anti-inflammatory and antioxidant properties
DA Negatu, M Gengenbacher, V Dartois, T Dick
Frontiers in Microbiology 11, 575586, 2020
Zplnomocnění: US National Institutes of Health
Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis
M Gengenbacher, N Nieuwenhuizen, A Vogelzang, H Liu, P Kaiser, ...
MBio 7 (3), 10.1128/mbio. 00679-16, 2016
Zplnomocnění: National Medical Research Council, Singapore
Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular
DA Negatu, JJJ Liu, M Zimmerman, F Kaya, V Dartois, CC Aldrich, ...
Antimicrobial agents and chemotherapy 62 (3), 10.1128/aac. 01571-17, 2018
Zplnomocnění: US National Institutes of Health, A*Star, Singapore, National Medical …
Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis
DA Negatu, Y Yamada, Y Xi, ML Go, M Zimmerman, U Ganapathy, ...
MBio 10 (2), 10.1128/mbio. 02781-18, 2019
Zplnomocnění: US National Institutes of Health, A*Star, Singapore, National Medical …
Rifabutin is active against Mycobacterium abscessus in mice
T Dick, SJ Shin, WJ Koh, V Dartois, M Gengenbacher
Antimicrobial agents and chemotherapy 64 (2), 10.1128/aac. 01943-19, 2020
Zplnomocnění: US National Institutes of Health
The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular Drugs
H Chen, SA Nyantakyi, M Li, P Gopal, DB Aziz, T Yang, M Gengenbacher, ...
Frontiers in Microbiology 9, 1627, 2018
Zplnomocnění: US National Institutes of Health, National Medical Research Council, Singapore
Mild Nutrient Starvation Triggers the Development of a Small-Cell Survival Morphotype in Mycobacteria
ML Wu, M Gengenbacher, T Dick
Frontiers in Microbiology 7, 947, 2016
Zplnomocnění: National Medical Research Council, Singapore
TBAJ-876, a 3, 5-dialkoxypyridine analogue of bedaquiline, is active against Mycobacterium abscessus
JP Sarathy, US Ganapathy, MD Zimmerman, V Dartois, M Gengenbacher, ...
Antimicrobial Agents and Chemotherapy 64 (4), 10.1128/aac. 02404-19, 2020
Zplnomocnění: US National Institutes of Health
Impact of immunopathology on the antituberculous activity of pyrazinamide
L Blanc, JP Sarathy, N Alvarez Cabrera, P O’brien, I Dias-Freedman, ...
Journal of Experimental Medicine 215 (8), 1975-1986, 2018
Zplnomocnění: US National Institutes of Health
Informace o publikování a financování jsou automaticky vybírány počítačovým programem